Quality improvement targets for regional variation in surgical end-stage renal disease care

JAMA Surgery

Volumn 150, Issue 8, 2015, Pages 764-770

  Zarkowsky, Devin S ^a   Hicks, Caitlin W ^b   Arhuidese, Isibor ^b   Canner, Joseph K ^b   Obeid, Tammam ^b   Qazi, Umair ^b   Schneider, Eric ^b   Abularrage, Christopher J ^b   Black, James H ^b   Freischlag, Julie A ^c   Malas, Mahmoud B ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ARTERIOVENOUS FISTULA; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMOBILITY; MALE; MORTALITY; NEOPLASM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TOTAL QUALITY MANAGEMENT; UNITED STATES; AGED; ARTERIOVENOUS SHUNT; INCIDENCE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; QUALITY IMPROVEMENT; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ADJUSTMENT; UNITED STATES;

EID: 84939864185     PISSN: 21686254     EISSN: 21686262     Source Type: Journal    
DOI: 10.1001/jamasurg.2015.1126     Document Type: Article

References (37)

1. National Institutes of Health. USRDS 2014 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health Diabetes and Digestive and Kidney Diseases; 2014.
2. Fistula First Breakthrough Initiative change concepts. http://www.fistulafirst.org. Accessed September 10, 2013.
3. Solid CA, Carlin C. Timing of arteriovenous fistula placement and Medicare costs during dialysis initiation. Am J Nephrol. 2012;35(6):498-508.
4. Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465-473.
5. Wasse H, Speckman RA, McClellan WM. Arteriovenous fistula use is associated with lower cardiovascular mortality compared with catheter use among ESRD patients. Semin Dial. 2008;21(5): 483-489.
6. Foley RN, Chen SC, Collins AJ. Hemodialysis access at initiation in the United States, 2005 to 2007: still "catheter first." Hemodial Int. 2009;13(4): 533-542.
7. DeSilva RN, Sandhu GS, Garg J, Goldfarb-Rumyantzev AS. Association between initial type of hemodialysis access used in the elderly and mortality. Hemodial Int. 2012;16(2): 233-241.
8. Malas MB, Canner JK, Hicks CW, et al. Trends in incident hemodialysis access and mortality [published online March 4, 2015]. JAMA Surg. doi: 10.1001/jamasurg.2014.3484.
9. Fistula First Outcomes Dashboard. Version 1.4. http://esrdncc.org/ffcl/for-ffcl-professionals/. Accessed November 23, 2014.
10. Hirth RA, Turenne MN, Woods JD, et al. Predictors of type of vascular access in hemodialysis patients. JAMA. 1996;276(16): 1303-1308.
11. Reddan D, Klassen P, Frankenfield DL, et al; National ESRD CPM Work Group. National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol. 2002;13(8): 2117-2124.
12. Hopson S, Frankenfield D, Rocco M, McClellan W. Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD Clinical Performance Measures Project. Am J Kidney Dis. 2008;52(4):753-760.
13. Goldfarb-Rumyantzev AS, Syed W, Patibandla BK, et al. Geographic disparities in arteriovenous fistula placement in patients approaching hemodialysis in the United States. Hemodial Int. 2014;18(3):686-694.
14. Axelrod DA, Lentine KL, Xiao H, et al. Accountability for end-stage organ care: implications of geographic variation in access to kidney transplantation. Surgery. 2014;155(5):734-742.
15. End Stage Renal Disease Network Coordinating Center. Our history. http://esrdncc.org. Accessed November 28, 2014.
16. US Renal Data System Coordinating Center. USRDS 2013 Researcher's Guide to the USRDS Database. Ann Arbor, MI: USRDS; 2013: 53. http://www.usrds.org/2013/rg/Researchers-Guide-2013.pdf?zoom-highlight=%22core+saf%22#search =%22core%20saf%22. Accessed May 20, 2015.
17. Longenecker JC, Coresh J, Klag MJ, et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study: Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol. 2000;11(3):520-529.
18. The USRDS and its database. Am J Kidney Dis. 1992;20(5)(suppl 2):15-19.
19. Wish JB. Data management to understand outcomes and trends in ESRD. Am J Kidney Dis. 1998;32(6)(suppl 4):S165-S172.
20. Zarkowsky DS, Arhuidese IJ, Hicks CW, et al. Racial/ethnic disparities associated with initial hemodialysis access [published online April 29, 2015]. JAMA Surg. doi:10.1001/jamasurg.2015.0287.
21. Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M. Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int. 2000;57(2):639-645.
22. Hicks CW, Canner JK, Arhuidese I, et al. Mortality benefits of different hemodialysis access types are age dependent. J Vasc Surg. 2015;61(2): 449-456.
23. O'Hare AM, Rodriguez RA, Hailpern SM, Larson EB, Kurella Tamura M. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA. 2010;304(2):180-186.
24. McClellan WM, Wasse H, McClellan AC, Holt J, Krisher J, Waller LA. Geographic concentration of poverty and arteriovenous fistula use among ESRD patients. J Am Soc Nephrol. 2010;21(10):1776-1782.
25. Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT. Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transplant. 2004;19(7):1808-1814.
26. Kessler M, Frimat L, Panescu V, Briançon S. Impact of nephrology referral on early and midterm outcomes in ESRD: Epidémiologie de l'Insuffisance Renale Chronique Terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis. 2003;42(3):474-485.
27. Wasse H, Hopson SD, McClellan W. Racial and gender differences in arteriovenous fistula use among incident hemodialysis patients. Am J Nephrol. 2010;32(3):234-241.
28. Chaudhary S, Hickson LJ, Hogan MC, et al. Predictors of fistula and graft placement in incident hemodialysis patients [abstract]. Blood Purif. 2011; 31:209.
29. Ori Y, Korzets A, Katz M, et al. The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy. Am J Kidney Dis. 2002;40 (4):745-752.
30. Savage MT, Ferro CJ, Sassano A, Tomson CR. The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study. Am J Kidney Dis. 2002;40(4):753-759.
31. Iwashima Y, Horio T, Takami Y, et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis. 2002;40(5): 974-982.
32. Ahearn DJ, Maher JF. Heart failure as a complication of hemodialysis arteriovenous fistula. Ann Intern Med. 1972;77(2):201-204.
33. Engelberts I, Tordoir JH, Boon ES, Schreij G. High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis. Am J Nephrol. 1995;15(4): 323-326.
34. Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous fistula. Hemodial Int. 2011;15(1):104-107.
35. Strand H, Parker D. Effects of multidisciplinary models of care for adult pre-dialysis patients with chronic kidney disease: a systematic review. Int J Evid Based Healthc. 2012;10(1):53-59.
36. Beaulieu M, Levin A. Analysis of multidisciplinary care models and interface with primary care in management of chronic kidney disease. Semin Nephrol. 2009;29(5):467-474.
37. Donca IZ, Wish JB. Systemic barriers to optimal hemodialysis access. Semin Nephrol. 2012;32(6): 519-529.